CS First Boston Keeps Merck at Underweight

Analyst Catherine Arnold says Merck's recent gross margin trends may be overstated based on her analysis

CS First Boston reiterated its underweight recommendation on Merck (MRK ).

To continue reading this article you must be a Bloomberg Professional Service Subscriber.